Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardised laxative therapy for opioid-induced constipation in adults with malignant or non-malignant pain
NL-OMON39001Phase 4Withdrawn
- Sponsor
- Mundipharma
- Start
- Jun 2013
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in opioid-induced constipation (OIC), sponsored by Mundipharma. Primary endpoints: Soft complete bowel movements per week, Soft complete bowel movements without straining per week and 13 more. Planned start Jun 2013; status: withdrawn.
02
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NL-OMON39001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39001.